Fifteen-minute consultation: Management of the upper limb in unilateral cerebral palsy.
Ambulatory Care Facilities
Botulinum Toxins
/ therapeutic use
Cerebral Palsy
/ physiopathology
Child
Hemiplegia
/ physiopathology
Humans
Medical History Taking
Muscle Spasticity
/ drug therapy
Neurologic Examination
Orthopedic Procedures
Physical Therapy Modalities
Splints
Upper Extremity
/ physiopathology
comm child health
general paediatrics
multidisciplinary team-care
neurodevelopment
neurodisability
Journal
Archives of disease in childhood. Education and practice edition
ISSN: 1743-0593
Titre abrégé: Arch Dis Child Educ Pract Ed
Pays: England
ID NLM: 101220684
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
23
10
2017
revised:
19
03
2018
accepted:
15
05
2018
pubmed:
5
7
2018
medline:
20
5
2020
entrez:
5
7
2018
Statut:
ppublish
Résumé
Children with unilateral cerebral palsy (UCP) have complex health, education and social care needs. Delayed gross motor milestones are the most common presenting feature, and much of the early management focuses on gross motor skills and lower limb management. In later childhood, adolescence and adulthood, upper limb function has significant impact on activity, participation and independence. There is clear pathophysiological rationale and emerging clinical evidence that earlier intervention to improve upper limb function is beneficial. Whereas most children with UCP are managed in secondary care, it is recommended that the assessment and delivery of specialist intervention for the upper limb occurs at a regional centre.
Identifiants
pubmed: 29970591
pii: archdischild-2017-313794
doi: 10.1136/archdischild-2017-313794
doi:
Substances chimiques
Botulinum Toxins
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
58-65Subventions
Organisme : Department of Health
ID : CDF-2013-06-001
Pays : United Kingdom
Informations de copyright
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Déclaration de conflit d'intérêts
Competing interests: JC has received personal honoraria for delivery of teaching and development of training materials from Ipsen Pharmaceuticals. JC has received funding for an alternative study regarding postural management in cerebral palsy from the National Institute for Health Research. AB is funded by a Career Development Fellowship award from the National Institute for Health Research. AB has received funding from Ipsen to develop educational materials around early detection of abnormal movements in infants. JP has also worked on this study.